Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Prostate Cancer Screening Among Men With High Risk Genetic Predisposition- a Prospective Cohort Study

NCT02053805 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT02053805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02053805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Prostate Cancer Screening Among Men With High Risk Genetic Predisposition- a Prospective Cohort Study
Lead sponsor
Rabin Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2014
Completion date
June 30, 2019
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 syndrome, brca2 syndrome, lynch syndrome